Management of Bosniak Kidney Cysts

Risk Stratification and Management

The European Association of Urology recommends risk-stratified management of Bosniak cysts based on malignancy potential, with Bosniak I/II cysts requiring no intervention, Bosniak IIF cysts needing active surveillance, Bosniak III cysts being managed with cautious surveillance, and Bosniak IV cysts requiring surgical intervention with nephron-sparing approaches when feasible 1
The 2019 Bosniak classification system predicts malignancy risk, with Bosniak I and II cysts having approximately 0% malignancy risk, Bosniak IIF cysts having approximately 10% malignancy risk, Bosniak III cysts having approximately 50% malignancy risk, and Bosniak IV cysts having 84-100% malignancy risk 1

The European Urology guidelines recommend multiphase contrast-enhanced CT or MRI for accurate Bosniak classification, with MRI demonstrating superior specificity compared to CT for characterizing renal lesions 1
Contrast-enhanced ultrasound (CEUS) can be helpful in specific cases for characterizing cystic lesions, but is not a replacement for CT or MRI in standard practice 4

The European Urology guidelines recommend preserving renal function through maximal parenchymal preservation, achieving negative surgical margins while minimizing removal of normal tissue, and avoiding prolonged warm ischemia during partial nephrectomy 5
Nephron-sparing approaches, such as partial nephrectomy, are preferred over radical nephrectomy, especially for cT1a tumors (<7 cm) and in patients with solitary kidney, bilateral tumors, familial RCC, or pre-existing chronic kidney disease 5

The European Urology guidelines do not recommend core biopsy for cystic renal masses due to low diagnostic yield, except for Bosniak IV cysts with focal solid areas amenable to sampling 1
Biopsy should only be considered for solid components, using a coaxial technique to minimize seeding risk 1

The European Urology guidelines recommend assigning CKD stage based on GFR and proteinuria for all patients with complex cysts, and considering nephrology referral for patients at high risk of CKD progression 5
Patients younger than 46 years should be evaluated for hereditary RCC syndromes, and pathologic evaluation of adjacent renal parenchyma should be performed after nephrectomy to assess for nephrologic disease 5